SCHEMBL13725690

SCHEMBL13725690

COc1ccc(OC(=O)c2cccc3c2NC(C(=O)O)C2CC=CC32)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 14/20 0.81
CDC25B P30305 1/20 0.67
HSPA1A P0DMV8 9/20 0.67
HSPA8 P11142 7/20 0.67
GAPDH P04406 6/20 0.67
TDP1 Q9NUW8 5/20 0.67
KDM4E B2RXH2 4/20 0.67
POLB P06746 4/20 0.67
MAPT P10636 4/20 0.67
HSD17B10 Q99714 4/20 0.67
L3MBTL1 Q9Y468 4/20 0.67
RECQL P46063 3/20 0.67
BLM P54132 3/20 0.67
ALDH1A1 P00352 3/20 0.67
HPGD P15428 3/20 0.67
THRB P10828 2/20 0.67
CACNA1B Q00975 2/20 0.67
APBA1 Q02410 2/20 0.67
MASP2 O00187 1/20 0.67
JUND P17535 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13726141 0.97 PTPN7 (0.87) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13724867 0.92 PTPN7 (0.81) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13725212 0.92 PTPN7 (0.88) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13724823 0.90 PTPN7 (0.85) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13726154 0.90 PTPN7 (0.81) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13725219 0.89 PTPN7 (0.77) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13725478 0.88 PTPN7 (0.82) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13725616 0.88 PTPN7 (0.89) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13725206 0.87 PTPN7 (0.87) PTPN7CDC25BHSPA1AHSPA8GAPDH
SCHEMBL13726148 0.86 PTPN7 (0.75) PTPN7CDC25BHSPA1AHSPA8GAPDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 US disclosed
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 US disclosed
WO-2009073550-A2 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS NISCH, NDUFS3, SDHA PTPN7 3898/4885CDC25B 1626/4885HSPA1A 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.